• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Osiris Therapeutics Inc

+ Add to Watchlist


13.2900 USD 0.3000 2.31%

As of 20:10:00 ET on 09/17/2014.

Snapshot for Osiris Therapeutics Inc (OSIR)

Open: 13.1000 Day's Range: 13.0200 - 13.4400 Volume: 200,008
Previous Close: 12.9900 52wk Range: 11.8004 - 19.7500 1-Yr Rtn: -18.96%

Stock Chart for OSIR

No chart data available.
  • OSIR:US 13.2900
  • 1D
  • 1M
  • 1Y
Interactive OSIR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OSIR

Current P/E Ratio (ttm) 273.9811
Estimated P/E(12/2014) -
Relative P/E vs. SPX 15.1526
Earnings Per Share (USD) (ttm) 0.0485
Est. EPS (USD) (12/2014) -0.1270
Est. PEG Ratio -
Market Cap (M USD) 455.98
Shares Outstanding (M) 34.31
30 Day Average Volume 130,024
Price/Book (mrq) 5.6400
Price/Sale (ttm) 11.7988
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OSIR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for OSIR

Osiris Therapeutics, Inc. researches and develops therapeutic products for the regeneration of human connective tissues. The Company is focusing its initial product development efforts on the regeneration of bone marrow stroma following high-dose cancer chemotherapy, and on the regeneration of bone in long bone and spinal defects.

Lode DebrabanderePresident/CEOPhilip R Jacoby JrCFO/Treasurer/Secretary
Frank D Czworka JrVP/General Manager:Wound CareAlla DanilkovitchVP:Research & Development
More Company Profile & Key Executives for OSIR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil